NCOA3 coactivator is a transcriptional target of XBP1 and regulates PERK–eIF2α–ATF4 signalling in breast cancer

Por Gupta, A, Hossain, M M, Miller, N, Kerin, M, Callagy, G, Gupta, S
Publicado no Oncogene (2016)

A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples

Por Chin, S-F, Daigo, Y, Huang, H-E, Iyer, N G, Callagy, G, Kranjac, T, Gonzalez, M, Sangan, T, Earl, H, Caldas, C
Publicado em 2003

Quantifying Tip60 (Kat5) stratifies breast cancer

Por McGuire, A., Casey, M. C., Shalaby, A., Kalinina, O., Curran, C., Webber, M., Callagy, G., Holian, E., Bourke, E., Kerin, M. J., Brown, J. A. L.
Publicado no Sci Rep (2019)

Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer

Por Casey, M.C., Prakash, A., Holian, E., McGuire, A., Kalinina, O., Shalaby, A., Curran, C., Webber, M., Callagy, G., Bourke, E., Kerin, M. J., Brown, J. A.
Publicado no BMC Cancer (2019)

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

Por Dawson, S-J, Makretsov, N, Blows, F M, Driver, K E, Provenzano, E, Le Quesne, J, Baglietto, L, Severi, G, Giles, G G, McLean, C A, Callagy, G, Green, A R, Ellis, I, Gelmon, K, Turashvili, G, Leung, S, Aparicio, S, Huntsman, D, Caldas, C, Pharoah, P
Publicado em 2010

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

Por Dawson, S-J, Makretsov, N, Blows, F M, Driver, K E, Provenzano, E, Le Quesne, J, Baglietto, L, Severi, G, Giles, G G, McLean, C A, Callagy, G, Green, A R, Ellis, I, Gelmon, K, Turashvili, G, Leung, S, Aparicio, S, Huntsman, D, Caldas, C, Pharoah, P
Publicado em 2010

Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study

Por Balmativola, D., Marchiò, C., Maule, M., Chiusa, L., Annaratone, L., Maletta, F., Montemurro, F., Kulka, J., Figueiredo, P., Varga, Z., Liepniece-Karele, I., Cserni, G., Arkoumani, E., Amendoeira, I., Callagy, G., Reiner-Concin, A., Cordoba, A., Bianchi, S., Decker, T., Gläser, D., Focke, C., van Diest, P., Grabau, D., Lips, E., Wesseling, J., Arisio, R., Medico, E., Wells, C., Sapino, A.
Publicado no Breast Cancer Res Treat (2014)